Finance

Lists
RZLT:NASDAQ
Rezolute Inc
$3.84
-2.78%
(-0.11) 1D
$3.83
-0.26% (-0.0100)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RZLT...
Open
$3.95
High
$3.95
Low
$3.66
Mkt. cap
369.76M
Avg. vol.
1.32M
Volume
2.53M
52-wk high
$11.46
52-wk low
$1.07
EPS
-$0.81
Beta
0.61
Shares outstanding
96.29M
No. of employees
68
Open
$3.95
High
$3.95
Low
$3.66
Mkt. cap
369.76M
Avg. vol.
1.32M
Volume
2.53M
52-wk high
$11.46
52-wk low
$1.07
EPS
-$0.81
Beta
0.61
Shares outstanding
96.29M
No. of employees
68
News stories
From web sources and news partners
About Rezolute Inc
CEO-
Employees68
Founded2010
HeadquartersRedwood City, California, United States
SectorBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to RZLT in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RZLT in the last 3 months.
Highest
Current $3.84
$6.00 (+56.25%)
Average
$5.50 (+43.23%)
Lowest
$5.00 (+30.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Maintained
$5.00
+30.2%
09/09/2026
Yun Zhong
Wedbush
Buy
Maintained
$6.00
+56.3%
08/25/2026
Debjit Chattopadhyay
Guggenheim
Buy
Reiterated
$11.00
+186.5%
06/15/2026
Jason Butler
Citizens JMP
Buy
Upgraded
$11.00
+186.5%
06/03/2026
Julian Harrison
BTIG
Buy
Maintained
$6.00
+56.3%
06/02/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$14.00
+264.6%
06/03/2026
Matt Hewitt
Craig-Hallum
Hold
Maintained
-
-
06/02/2026
Catherine Novack
JonesTrading
Buy
Reiterated
$6.00
+56.3%
06/02/2026
Pete Stavropoulos
Cantor Fitzgerald
Hold
Maintained
-
-
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.73M
13.03M
13.33M
10.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.12M
6.79M
9.39M
5.48M
Operating expense
25.85M
19.82M
22.72M
15.87M
Total operating expenses
25.85M
19.82M
22.72M
15.87M
Operating income
-25.85M
-19.82M
-22.72M
-15.87M
Other non operating income
15.00K
-15.00K
-
-
EBT including unusual items
-24.39M
-18.15M
-22.77M
-16.17M
EBT excluding unusual items
-24.39M
-18.15M
-21.27M
-14.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.39M
-18.15M
-22.77M
-16.17M
Net profit margin
-
-
-
-
Earnings per share
-0.26
-0.18
-0.22
-0.16
Interest and investment income
1.44M
1.68M
1.45M
1.20M
Interest expense
-
-
-
-
Net interest expenses
1.44M
1.68M
1.45M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.84M
-19.81M
-22.71M
-15.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps